Owl Creek Asset Management’s Starling Oncology Warrant STLNW Stock Holding History

Owl Creek Asset Management’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-49,999	Closed	-$85K	–	153
2020 Q3	$85K	Hold	49,999	–	–	0.01%	105
2020 Q2	$73K	Buy	+49,999	New	+$71.7K	0.01%	92

Other funds holding STLNW

SRCM

Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

ECM

Element Capital Management New York $3.2B AUM 29.54% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Bulldog Investors Saddle Brook, New Jersey $455M AUM 2.3% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Owl Creek Asset Management's STLNW Position: Q4 2020 in Review

Owl Creek Asset Management sold out of Starling Oncology Warrant (STLNW) in Q4 2020, closing a stake of 49,999 shares — an estimated $85K sold.

Owl Creek Asset Management first reported a position in STLNW in Q2 2020 and held it in 2 quarters. The position peaked at $85K in Q3 2020. 25 funds tracked by Wall St. Rank hold STLNW as of Q4 2020.

Owl Creek Asset Management reported no remaining Starling Oncology Warrant position as of Q4 2020 after selling out during the quarter.
Owl Creek Asset Management sold 49,999 Starling Oncology Warrant shares in Q4 2020, an estimated $85K.
Owl Creek Asset Management first reported a position in Starling Oncology Warrant in Q2 2020 and held it in 2 quarters.
Owl Creek Asset Management's Starling Oncology Warrant position peaked at $85K in Q3 2020.
25 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q4 2020.

Based on Owl Creek Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.